Back
Day Range
$115.00
$115.00
52-Week Range
$66.68
$115.00
Volume
217
50D / 200D Avg
$104.50
/
$85.30
Prev Close
$115.00
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 171.3 | 0.3 |
| P/B | 5.2 | 2.9 |
| ROE % | 3.1 | 3.7 |
| Net Margin % | 3.1 | 3.8 |
| Rev Growth 5Y % | 13.9 | 10.0 |
| D/E | 0.6 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$4.58
$4.51 – $4.64
|
520 M | 1 |
| FY2028 |
$3.21
$3.17 – $3.26
|
450 M | 1 |
| FY2027 |
$2.30
$2.27 – $2.33
|
390 M | 1 |
Key Takeaways
Revenue grew 13.92% annually over 5 years — strong growth
Earnings grew 136.65% over the past year
ROE of 3.06% is below average
Generating 9.34M in free cash flow
P/E of 171.25 — premium valuation
PEG of 0.75 suggests growth is underpriced
Growth
Revenue Growth (5Y)
13.92%
Revenue (1Y)19.76%
Earnings (1Y)136.65%
FCF Growth (3Y)182.33%
Quality
Return on Equity
3.06%
ROIC0.33%
Net Margin3.10%
Op. Margin0.72%
Safety
Debt / Equity
0.57
Current Ratio2.21
Interest Coverage0.26
Valuation
P/E Ratio
171.25
P/B Ratio5.18
EV/EBITDA803.78
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 19.76% | Revenue Growth (3Y) | 12.70% |
| Earnings Growth (1Y) | 136.65% | Earnings Growth (3Y) | 267.26% |
| Revenue Growth (5Y) | 13.92% | Earnings Growth (5Y) | 5.12% |
| Profitability | |||
| Revenue (TTM) | 269.26M | Net Income (TTM) | 8.35M |
| ROE | 3.06% | ROA | 1.49% |
| Gross Margin | 75.89% | Operating Margin | 0.72% |
| Net Margin | 3.10% | Free Cash Flow (TTM) | 9.34M |
| ROIC | 0.33% | FCF Growth (3Y) | 182.33% |
| Safety | |||
| Debt / Equity | 0.57 | Current Ratio | 2.21 |
| Interest Coverage | 0.26 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 171.25 | P/B Ratio | 5.18 |
| P/S Ratio | 5.31 | PEG Ratio | 0.75 |
| EV/EBITDA | 803.78 | Dividend Yield | 0.00% |
| Market Cap | 1.43B | Enterprise Value | 1.55B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 269.26M | 224.83M | 212.01M | 182.82M | 159.88M |
| Net Income | 8.35M | 3.53M | 619,000.0 | -5.78M | 6.84M |
| EPS (Diluted) | 0.67 | 0.26 | 0.05 | -0.49 | 0.58 |
| Gross Profit | 204.33M | 178.68M | 167.57M | 135.39M | 121.57M |
| Operating Income | 1.93M | 7.87M | 9.10M | -1.87M | 11.01M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 559.92M | 459.96M | 349.53M | 327.89M | 298.18M |
| Total Liabilities | 284.05M | 190.32M | 94.58M | 90.11M | 74.18M |
| Shareholders' Equity | 275.87M | 269.65M | 254.96M | 237.78M | 224.00M |
| Total Debt | 157.72M | 120.29M | 27.39M | 52.04M | 24.07M |
| Cash & Equivalents | 32.97M | 138.69M | 25.20M | 20.60M | 82.64M |
| Current Assets | 195.28M | 265.95M | 141.42M | 137.88M | 175.48M |
| Current Liabilities | 88.17M | 51.02M | 45.96M | 39.53M | 34.71M |